After equilibration of the dye, C5b-9 assembly was initiated by the addition of C8 and C9 (see figure legends).
Steady-state fluorescence was monitored continuously throughout.
All fluorescence measurements were performed using an SLM 48005 equipped for sample stirring and temperature control and modified with a light tight port for sample injection.
To correct for fluctuations in lamp output and instrument response, reference was routinely made to a quantum standard (rhodamine B in a sealed cuvette).
Calibration of diS-C,-(5) fluorescence to Em
Calibration of diS-C3- (5) fluorescence to the platelet membrane potential was performed by methods previously described.'2
Radiolabeling.
C9 was nadiolabeled with Na 1251 by the use of Enzymobeads (Bio-Rad Laboratories, Richmond, Calif) as previously described.'5
The specific activity was 0.18 mCi/mg.
Density-gradient analysis of C5b-9 platelets.
To analyze the membrane distribution of bound C5b-9 complexes, C5b67 platelets were assembled as described earlier and gel-filtered on a Sepharose column (30 x 0.9 cm) equilibrated in Medium I to remove unbound complement proteins. To 2.5 x 108 gel-filtered C5b67 platelets, 2.5 pg of C8 and 0.6 pg of '25I-labeled C9 were added. Matched-pain controls were prepared by omitting C8. After incubation for 1 5 minutes at 37 #{176}C, the samples were applied to discontinuous isotonic Percoll gradients made of I mL of 50%, 7 mL of 25%, and 5 mL of 7% Percoll in Medium II (omitting phosphate). The gradients were centrifuged in a Beckman J2-2I centrifuge for 30 minutes at 29,000 g, fractionated (0.4 ml per fraction), assayed for radioactivity and phosphorus, and prepared for electron microscopy.
Phosphorus assay. 
